You have read all your free articles, to continue reading subscribe to read the rest of this content.
Nexstim's business partner PO Medica AB has sold two Navigated Brain Therapy (NBT) systems to two different hospitals Sweden. Both hospitals will be the first in Sweden to have the NBT systems and it will be their first time using navigated Transcranial Magnetic Stimulation (TMS) for the treatmeAlready a subscriber Login…
NeuroVive Pharmaceutical has announced that the license agreement with Arbutus Biopharma (formerly OnCore Biopharma) has been terminated and all rights to the NVP018 compound have been reverted back to NeuroVive. The agreement, signed in 2014, was related to the development and commercializationAlready a subscriber Login You have read all your free…
Novo Nordisk has announced the launch of a new social responsibility strategy, Defeat Diabetes. The strategy strengthens Novo Nordisk’s commitment and introduces new long-term ambitions to provide access to affordable diabetes care to vulnerable patients in every country and to ensure that no cAlready a subscriber Login You have read…
Recipharm has announced the acquisition of GenIbet, a Portuguese CDMO, specializing in the manufacture of biological clinical trial material and novel modalities such as viral vectors, RNA and microbiome. The acquisition forms part of Recipharm’s strategy to grow in the biologics market, with aAlready a subscriber Login You have read…
